Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MCA Permanent Order Banning Aristolochia Use Proposed

This article was originally published in The Tan Sheet

Executive Summary

The U.K.' s Medicines Control Agency has issued a proposal to continue, on a permanent basis, current provisions prohibiting the distribution of products containing the Aristolochia species or herbal ingredients that may be confused with the species.
Advertisement

Related Content

Chinese Herbal Medicines Coalition Calls For Lifting Of Aristolochia Ban
Chinese Herbal Medicines Coalition Calls For Lifting Of Aristolochia Ban
Urothelial Cancer, Chinese Herbs Linked In NEJM Study
Aristolochic Acids Kidney AEs Subject Of Pending FDA Import Alert
Aristolochic Acids Kidney AEs Subject Of Pending FDA Import Alert

Topics

Advertisement
UsernamePublicRestriction

Register

PS092127

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel